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In this issue, Park et al.1) present their experience with the use of 
a novel, fenestrated aortic arch stent graft (FASG) with a preloaded 
catheter for supra-aortic vessels. The authors have done an 
outstanding job highlighting a subject of increasing importance in 
acute clinical care, namely, performing thoracic endovascular aortic 
repair (TEVAR) in a short landing zone for aortic arch pathology. 
Although TEVAR is an effective therapy for various aortic arch 
pathologies, particularly in patients with a high operative risk or 
an emergent condition, the involvement of supra-aortic vessels 
limits the application of TEVAR.2)3) Operators have modified a 
standard device by on-table creation of fenestrations and markers. 
The use of such operator-modified devices offers an opportunity 
for expanded technology usage.4) Inoue et al.5) were the first to 
introduce the endovascular technique for aortic arch repair. To date, 
some reports on the use of fenestrated stent grafts for aortic arch 
pathologies have been published.6)7) But, those types of fenestrated 
stent grafts were reported to have inaccurate deployment and 
stent graft migration risks. Moreover, the fenestrated site may be 
difficult to accurately fit into supra-aortic vessels. Contrary to the 
aforementioned devices, this new FASG has a preloaded catheter 
which allows an additional guidewire for advancement into supra-
aortic vessels in advance, and makes it easier to deploy the stent 
graft without enhancing the risk of stent graft migration. 
 Several issues in the present study should be addressed. First, 
this study was not conducted in diseased human aortas, but in 
healthy pigs whose aortas were free of significant enlargement 
or dissection. The anatomy of supra-aortic vessels in pigs and 
humans is fundamentally different. However, no diseased aortic 
arch experimental models have been developed due to technical 
difficulties, while several abdominal aortic aneurysm models have 
already been used. Second, this FASG is likely to be appropriate for 
aortic arch pathologies that are adjacent to the lesser curvature. 
This is especially true where supra-aortic vessels take off at narrow 
intervals or branch from an acute angulated aortic arch. If this 
FASG is applied in an aforementioned aortic arch pathology in the 
greater curvature, there is a high possibility that endoleaks from 
the supra-aortic vessels might occur, causing serious pressure 
overload between the aortic wall and the implanted stent graft. 
Other important unknowns regarding this FASG are its ability to 
provide sustainable patency and strong radial force without serious 
complications. In this study, the authors have demonstrated that 
excellent short-term results can be achieved using this FASG in 
10 pigs.1) In the literature, the risk of cerebral infarction seems 
to be higher after placement of a stent graft with a side branch, 
especially when it involves the brachiocephalic and left common 
carotid arteries.6-8) At the present time, the most popular method is 
termed ‘hybrid’ therapy and involves prophylactic transposition or 
bypass graft placement to provide flow to the brain or arms. 
This FASG is a promising device for aortic arch applications. We 
strongly suggest that this FASG might be the best choice for a 
patient with traumatic aortic arch dissection that is located in the 
lesser curvature with a healthy proximal short landing zone. The 
long term feasibility, durability and safety of this FASG remain to 
be addressed in future human studies.
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